Endovascular Treatment for Chronic Cerebrospinal Venous Insufficiency
Endovascular Correction of Chronic Cerebrospinal Venous Insufficiency (CCSVI) and Evaluation of Influence of These Treatments on the Symptoms of Multiple Sclerosis
What it found
We found no results in the registry or in papers.
This trial finished 16 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- balloon angioplasty and/or stenting
What it measured
Main measures
Change in clinical symptoms of multiple sclerosis measured by Extended Disability Severity Score (EDSS), Multiple Sclerosis Impact Scale-29 (MSIS-29), Fatigue Severity Scale (FSS) and heat intolerance
6 months after the procedure
Disability progressionFatigueQuality of life (reported by participants)
Who could take part
MS (type not specified)
Show the full criteria
Inclusion criteria
* patients with clinically defined multiple sclerosis
Exclusion criteria
* contraindication for endovascular procedure performed in local anesthesia
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The aim of this study is to assess the efficacy of endovascular treatment (balloon angioplasty and/or stenting) for the improvement of clinical symptoms in multiple sclerosis patients.
Papers
Loading reviews and guidelines…
History
Started
Mar 2010
Main results due
Oct 2010
Finished
Dec 2012